302 related articles for article (PubMed ID: 28223528)
1. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
2. RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3
Huynh PN; Christensen SB; McIntosh JM
Cells; 2022 Nov; 11(22):. PubMed ID: 36428990
[TBL] [Abstract][Full Text] [Related]
3. RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia.
Christensen SB; Hone AJ; Roux I; Kniazeff J; Pin JP; Upert G; Servent D; Glowatzki E; McIntosh JM
Front Cell Neurosci; 2017; 11():219. PubMed ID: 28785206
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.
Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK
Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933
[TBL] [Abstract][Full Text] [Related]
5. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
6. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats.
Huynh PN; Giuvelis D; Christensen S; Tucker KL; McIntosh JM
Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877728
[TBL] [Abstract][Full Text] [Related]
7. α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia.
Mohammadi S; Christie MJ
Mol Pain; 2014 Oct; 10():64. PubMed ID: 25274008
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.
Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH
J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094
[TBL] [Abstract][Full Text] [Related]
9. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
10. The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.
Holtman JR; Dwoskin LP; Dowell C; Wala EP; Zhang Z; Crooks PA; McIntosh JM
Eur J Pharmacol; 2011 Nov; 670(2-3):500-8. PubMed ID: 21944926
[TBL] [Abstract][Full Text] [Related]
11. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979
[TBL] [Abstract][Full Text] [Related]
13. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
Hone AJ; Servent D; McIntosh JM
Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
[TBL] [Abstract][Full Text] [Related]
14. Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and Ca
Arias HR; Tae HS; Micheli L; Yousuf A; Ghelardini C; Adams DJ; Di Cesare Mannelli L
Neuropharmacology; 2020 Sep; 175():108194. PubMed ID: 32540451
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
16. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
Wala EP; Crooks PA; McIntosh JM; Holtman JR
Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
18. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
19. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
20. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
